Objective: To examine the effect of Medicare Part D on racial/ethnic disparities in having any drug coverage and in sources of payment for drug expenditure. Methods: We used nationally representative data on whites, African-Americans, and Hispanics aged 55 and older from the [2002][2003][2004][2005][2006][2007][2008][2009] Medical Expenditure Panel Survey to analyze disparities in having any drug coverage and in sources of coverage for individuals aged 65 and older as compared with those for adults aged 55-63 without Medicare. Results: There was no disparity in the probability of drug coverage for African-American or Hispanic compared to white Medicare beneficiaries, before or after 2006. There were, however, differences in the sources of coverage. African-Americans and Hispanics over the age of 65 had lower rates of private coverage than whites. This disparity in private coverage was completely offset by minorities' higher rates of drug coverage through Medicaid before 2006 and through Part D since 2006. In contrast, among individuals aged 55-63, there are large and persistent disparities in the probability of having drug coverage throughout the period. Discussion: Pronounced racial/ethnic disparities in drug coverage in the years just before Medicare eligibility are eliminated by access to public coverage at age 65. This was true even before the introduction of Part D.
medications to cope with costs (Balkrishnan, 1998; Soumerai et al., 2006) . Therefore, one might have expected the coverage increases associated with Part D to reduce racial/ethnic disparities in use and spending. Somewhat surprisingly, however, this seems not to have been the case (Chen, Rizzo, & Ortega, 2011; Mahmoudi & Jensen, 2013) . Mahmoudi and Jensen (2013) noted that Part D reduced the white/Hispanic disparities in utilization, total, and out-of-pocket costs of prescription drugs but increased the white/African-American disparity in total prescription cost, with no effects on other utilization and cost measures.
Is the persistence of disparities in utilization an indication that Part D did not eliminate disparities in coverage-or does it simply show that disparities in utilization occur even conditional on coverage? In short, what exactly happened to racial/ethnic disparities in drug coverage as a result of Medicare Part D?
Our aims in this study were to assess the effect of Medicare Part D on racial/ethnic disparities in having any drug coverage and in sources of coverage. We hypothesized that before Part D, seniors who were either non-Hispanic African-American (African-American) or Hispanic (of any race) would be less likely than non-Hispanic whites (white) to have drug coverage. We asked whether Part D reduced disparities in the probability of having drug insurance and whether it differentially affected the sources of such coverage for minorities compared with whites.
Background
Prior to 2006, more than 25% of Medicare beneficiaries had no prescription drug coverage (Safran et al., 2002) . For Medicare beneficiaries who were below 200% of the federal poverty level (FPL), Medicaid and state-funded pharmacy assistance programs were the main sources of coverage. Seniors who were above the 200% threshold had drug coverage mainly through employers, Medicare managed care (MMC), or other private insurers (Safran et al., 2005) .
Further, Previous studies indicate that among beneficiaries with drug coverage, the generosity of that coverage varies significantly (Adams, Soumerai, & Ross-Degnan, 2001) . While Medicaid or other state-and employer-sponsored drug coverage was associated with greater utilization of drugs and lower out-of-pocket costs, private coverage was only associated with lower out-of-pocket costs compared with costs to beneficiaries who had no drug coverage (Adams et al., 2001; Poisal & Chulis, 2000; Poisal & Murray, 2001; Safran et al., 2005) .
This article contributes to the literature by focusing specifically on the effects of Part D on racial/ethnic disparities in drug coverage and in sources of this coverage.
Study Data and Methods

Data
We used the household component (HC) files of the 2002-2009 Medical Expenditure Panel Survey (MEPS), a nationally representative survey of the U.S. civilian, noninstitutionalized population conducted annually by the Agency for Healthcare Research and Quality (AHRQ; Cohen et al., 1996) . We limited our attention to individuals who self-reported being African-American, white, or Hispanic based on the MEPS' questions regarding race and ethnicity. Other minority subpopulations were not examined due to small sample sizes in the MEPS.
Our initial sample included a total of 45,463 white, African-American, and Hispanic respondents from the 2002-2009 MEPS, 26,109 of whom were 65 and older Medicare beneficiaries and 19,354 of whom were 55-63 year-old individuals without Medicare. After removing 1,225 records with missing variables, our final and complete sample includes 44,238 individuals (Figure 1) .
Throughout, we adjust for the clustered and stratified survey design of the MEPS and weight all estimates using AHRQ-supplied pooled sampling weights.
Dependent and Independent Variables
The MEPS survey includes two sources of information regarding an individual's drug coverage: the drug insurance section and the prescription expenditures reported in the sources of coverage section. The drug insurance section asks individuals whether they currently hold any drug coverage. Starting in 2006, a separate question was added for Medicare beneficiaries about whether their drug coverage was obtained through Part D. The expenditures section asks about each prescription filled during the previous round, if any, and the total and out-of-pocket cost of each prescription. With participants' consent, MEPS staff verified the reported prescription using actual pharmacy records (AHRQ, 2011) . If consent was not granted, the data are the participant's own self-reported information.
Drug insurance is measured as a binary (0,1) variable that equals 1 if the drug insurance section or the expenditures section of the MEPS reveals the presence of drug coverage and 0 otherwise. Andersen's conceptual framework guides our choice of explanatory variables for the models to be estimated (Andersen, 1968) . Each model includes need-related variables such as age, gender, and measures of health and functioning. We also include predisposing and enabling factors such as marital status, education, income, health insurance, location, and English language. To control for health and functioning, we include a range of variables. Two (0,1) indicators for whether self-rated health and self-rated mental health, respectively, are fair or poor as opposed to good or better are included, as well as binary indicators for reported diagnosis of heart problems, diabetes, asthma, arthritis, or hypertension. For physical functioning, we include the number of functional limitations reported (ranging from 0 to 21). Marital status is measured with a (0,1) indicator for being currently married. Education is measured by a series of mutually exclusive binary indicators for less than high school, college degree, graduate school degree, or another degree, with high school being the reference category. Household income is measured using four mutually exclusive categories: poor or near poor (household income <125% of the FPL), low income (125-199% of FPL), middle income (200-399% of FPL), and high income (at least 400% of FPL), with low income being the reference category. For health insurance we include two (0,1) indicators for whether the individual reports having Medicaid and/or private health insurance at any time during the past year. We also control for residing in an urban area and for U.S. Census region, with the Northeast as the reference category. Finally, we adjust for English language fluency, with a binary indicator for whether the MEPS interview was conducted in English.
Linear Probability Model
We adopted a difference-in-difference-in-differences (DDD; Wooldridge, 2007) Although having drug insurance is a binary outcome measure, we used linear regression applying the DDD method because of well-documented complexity in interpreting the interaction terms in a logit model (Ai & Norton, 2003; Karaca-Mandic, Norton, & Dowd, 2012) . We used robust standard errors to account for heteroscedasticity. Furthermore, we tested for similar trend patterns in racial/ ethnic disparity before Part D and did not find any significant differences in disparity trends within the 55-to-63 and the 65-and-older groups prior to 2006. We used Stata version13 for our analysis.
Results
Figure 2 shows trends (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) ) in having drug insurance based on age and year, for white, African-American, and Hispanic individuals in each group. This figure summarizes our main findings very well; for the near-elderly, there are large racial/ethnic disparities in the probability of having any drug coverage throughout this period, with whites the most likely to have coverage, followed by AfricanAmericans, then Hispanics. Among Medicare beneficiaries, there are no racial or ethnic disparities either before or after Part D. The overall probability of having coverage rises in 2006, with the implementation of Part D, but it does so for all racial/ethnic groups. provides the same information for the near-elderly adults). On average, 73% of the 65-and-older white, AfricanAmerican, and Hispanic Medicare beneficiaries had drug insurance before 2006; Part D increased coverage for whites and minorities to 93%-95%. The average age of Medicare seniors in both periods was about 74, with Hispanics being slightly younger than whites. Compared to whites, minority Medicare seniors were less healthy and had more functional limitations and chronic conditions. In particular, the prevalence of diabetes and high blood pressure was much higher among African-Americans and Hispanics than among whites (e.g., 20% of whites, 34% of African-Americans, and 35% of Hispanics were diagnosed with diabetes). Compared to 57% of whites, 33% of African-Americans, and 48% of Hispanics were married. Minorities had less education (43% of AfricanAmericans and 66% of Hispanics vs 18% of whites reported less than a high school education), and had lower annual household incomes (about 30% of minorities vs 15% of whites had a household incomes of <125% of FPL). Older minorities relied heavily on Medicaid; compared with 5% of white seniors, 32% of Hispanics, and 20% of African-Americans were dual eligible (had Medicaid and Medicare). Further, compared with 49% of whites, 29% of African-Americans, and 19% of Hispanics had private health insurance. Finally, Table 1 shows that more than half (53%) of Hispanic seniors did not speak English fluently. Figure 3 shows different sources of coverage between white and minorities throughout the entire period-before and after Part D. Prior to 2006, on average, about a quarter to a third of drug costs for older minorities, compared with 6% for older whites, was covered by Medicaid; compared with 44% for older African-Americans and 46% for older Hispanics, the total out-of-pocket costs for older whites was 53% of their total medication costs. Private drug coverage accounted for a larger share of whites' medication expenditures than minorities', but this was more than offset by the higher Medicaid share among minorities. After 2006, Medicare was the main source of coverage for all three subgroups. The out-of-pocket share, however, remained higher for whites than for minorities.
After 2006, the out-of-pocket share dropped substantially for all three groups, but was persistently highest for Hispanics. The share of drug cost paid by private insurance was highest for whites both before and after 2006. Compared to seniors, there was less reliance on Medicaid as a source of drug coverage across the board; Medicaid, on average, covered about 6% of drug costs among nearelderly whites, 23% for African-Americans, and 20% for Hispanics. Before and after Part D, private insurance remained the major source of coverage for the white and minority near elderlies. Table 2A and 3A in the Supplementary Material provide significant values for differences between older whites and minorities and for the changes observed over time in each group. In short, although racial/ethnic disparity in drug coverage had disappeared long before the implementation of Part D, there were substantial differences between older whites and minorities in out-of-pocket expenditure. After 2006, out-of-pocket expenditure dropped for all three subgroups. However, it remained higher among whites. Table 2 reports the regression results for the DDD effect of Part D on having drug coverage, controlling for demographic and socioeconomic characteristics. Most importantly, our data indicates that Medicare Part D had no effect on racial/ethnic disparity in drug coverage (the interaction term of being African-American, 65-and-older, Among other covariates, our regression estimates indicate that having chronic conditions (e.g., diabetes by .06; p < .001), being married (by .03; p < .001), having a college degree (by .01; p < .015), having a high income (by .05; p < .001), having Medicaid (by .24; p < .001), having private insurance (by .23; p < .001), living in a metropolitan area (by .05; p < .001), speaking English (by .07; p < .001), being African-American and having Medicaid (by .06; p = .006) or private insurance (by .11; p < .001), and being Hispanic and having Medicaid (by .11; p < .001) or private insurance (by .18; p < .001) increased the probability of having drug coverage.
Discussion
This study has two main findings. First, prior to and after 2006, there was no racial/ethnic disparity in drug coverage among 65-and-older Medicare beneficiaries. became the default source of drug coverage for all beneficiaries who had been receiving it through Medicaid-has maintained the lack of disparity since it began in 2006. Our findings reveal the importance of social safety programs such as Medicaid in providing coverage for the most vulnerable population in years prior to Part D. Previous research supports our findings (Davis, Poisal, Chulis, Zarabozo, & Cooper, 1999; Poisal & Chulis, 2000; Poisal & Murray, 2001 ). Davis and colleagues, using the 1995 Medicare Current Beneficiary Survey (MCBS), show that by 1995, about 65% of all Medicare beneficiaries had some form of outpatient drug benefits. By 1998, the percentage of beneficiaries with drug insurance increased to 73%, leaving only 27% without coverage. Medicare Part D, enacted in 2003, was the result of a long debate over the importance of drug coverage for Medicare beneficiaries. Although there was no racial/ethnic disparity in drug coverage between white and minority Medicare beneficiaries, Part D increased the drug coverage for all beneficiaries.
Between white and minority near elderlies, there still exist large and significant disparities in drug coverage. The main source of drug coverage among the near elderlies is employer-sponsored insurance. Part D did not affect this population. It is important, however, to note a downward trend in disparity in drug coverage between near-elderly whites and Hispanics over time. During the period of study, private health insurance increased faster among nearelderly Hispanics. This sharp increase in having private insurance reduced the drug coverage gap between whites and Hispanics. This might be mainly due to significant improvements in education and therefore type of employment among the near-elderly Hispanics (Table A1 in the Supplementary Material).
Our findings show large differences in sources of coverage between whites and minorities. Prior to Part D, about half of medication costs was covered out of pocket, with whites having the most and African-American having the least out-of-pocket spending. Medicaid and private insurance were the second sources of coverage for minorities and whites, respectively. After Part D, Medicare became the main source of coverage for all beneficiaries. For the near-elderly group, the top two main sources of coverage over the study period were private insurance and out of pocket. More whites than minorities held private insurance. Therefore, out-of-pocket spending was higher among Hispanics than it was among whites.
This study was not without limitations. First, the most suitable comparison group would have been Medicare beneficiaries 65 and older who were not eligible for Part D. Because no such group exists, our study, like most prior studies, used adults aged 55-63 without Medicare as a comparison group. Second, research indicates that MMC has (Mahmoudi & Jensen, 2013; McGuire et al., 2011) . MMC could have been another source of drug coverage that, along with Medicaid, eliminated disparity in drug coverage. However, the variable indicating enrollment in MMC was not available in the MEPS until 2006. Therefore, we did not include it in our model.
In summary, Medicare Part D increased prescription drug coverage for all Medicare seniors. However, because of high enrollment of older minorities in Medicaid, through which many of them had some type of drug coverage prior to 2006, there were no racial/ethnic disparities in having drug insurance among Medicare seniors prior to or after Part D. There were significant differences in sources of coverage between whites and minorities in both time periods. What this means is that eliminating racial/ethnic disparities requires more than making coverage available. At the same time, considering the large and significant disparities among the near elderlies, it is an important first step. Affordable Care Act will likely increase access to drug coverage for the near elderly (at least in states expanding Medicaid, and also through exchanges). But we should not fool ourselves into thinking that this will eliminate disparities in utilization, even if it eliminates gaps in coverage.
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